Beryl Drugs Ltd.
Search Company
  You can view the Income statement for the last 5 years.
ISIN No INE415H01017 52Wk High (Rs.) 30 BV (Rs.) 18.30 FV (Rs.) 10.00
Bookclosure 30/09/2024 52Wk Low (Rs.) 16 EPS (Rs.) 1.14 P/E (X) 16.13
Mkt Cap. (Rs. Cr.) 9.33 P/BV (X) 1.01 Div Yield (%) 0.00 Mkt Lot 1
 
(Rs. in Crs.)
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Net Sales/Income from operations21.1526.7326.8914.6014.09
Total Income From Operations21.1526.7326.8914.6014.09
      
EXPENDITURE     
Consumption of Raw Materials11.1213.3114.238.717.45
Increase/Decrease in Stocks-0.34-0.170.31-0.30-0.03
Employees Cost2.211.931.701.311.18
Depreciation1.251.200.811.091.27
Other Expenses6.929.388.714.484.05
Total Expenses21.1625.6525.7615.2813.92
      
P/L Before Other Inc. , Int., Excpt. Items & Tax-0.011.081.13-0.680.17
Other Income1.410.400.270.160.19
P/L Before Interest, Excpt. Items & Tax1.401.471.40-0.510.36
Interest0.530.460.420.440.47
P/L Before Exceptional Items & Tax0.871.010.98-0.95-0.10
Exceptional Items0.000.000.000.000.45
P/L Before Tax0.871.010.98-0.950.35
Tax0.290.240.22-0.290.11
P/L After Tax from Ordinary Activities0.580.770.77-0.660.24
Net Profit/Loss For the Period0.580.770.77-0.660.24
      
Equity Share Capital5.075.075.075.075.07
Reserves And Surplus4.413.832.972.202.84
EPS Before Extra Ordinary *     
Basic EPS (Rs.)1.141.521.52-1.300.47
Diluted EPS (Rs.)1.141.521.52-1.300.47
EPS After Extra Ordinary *     
Basic EPS (Rs.) 1.141.521.52-1.300.47
Diluted EPS (Rs.) 1.141.521.52-1.300.47
      
PBITOE Margin (%)-0.064.034.20-4.641.23
PBTE Margin (%)4.093.773.65-6.50-0.73
PBT Margin (%)4.093.773.65-6.502.46
PAT Margin (%)2.732.872.84-4.511.70